Dr. Theresa M Alexander, MD Family Medicine Medicare: Not Enrolled in Medicare Practice Location: 1006 S Edgewood Dr, Knox, IN 46534 Phone: 574-772-5505 Fax: 574-772-6151 |
Thomas Michael Browne, M.D. Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 104 E Culver Rd Ste 102, Knox, IN 46534 Phone: 574-772-7918 Fax: 574-772-0894 |
Dr. Walter E Fritz, M.D. Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 1002 S Edgewood Dr, Knox, IN 46534 Phone: 574-772-2188 Fax: 574-772-2190 |
News Archive
Positive thoughts bring positive things to people and it's well documented these expectations have helped people recover from a number of health conditions. But until now, not much was known about the correlation between that belief and the recovery from injuries like whiplash.
In a perspective piece in The Globalist, Contributing Editor Cesar Chelala calls for more attention to be paid to the role of women in reducing hunger worldwide. "Giving women the same tools and resources as men, such as financial support, education and access to markets, could reduce the number of hungry people worldwide by up to 150 million, according to the Food and Agriculture Organization," he writes.
Medtronic, Inc. today announced data from the STOP AF (Sustained Treatment of Paroxysmal Atrial Fibrillation) clinical trial during late-breaking sessions at the 59th Annual Scientific Session of the American College of Cardiology in Atlanta. The data showed superiority over anti-arrhythmic drugs, with 69.9 percent of patients with paroxysmal atrial fibrillation (PAF) treated with the Arctic FrontĀ® Cardiac CryoAblation Catheter System remaining free of atrial fibrillation (AF) one year after cryoablation, compared to 7.3 percent on drug therapy.
Nearly 10 years after the discovery that birds make a hormone that suppresses reproduction, University of California, Berkeley, neuroscientists have established that humans make it too, opening the door to development of a new class of contraceptive and possible treatments for cancer or other diseases.
Celldex Therapeutics, Inc. today reported financial results for the fourth quarter and year ended December 31, 2009. Celldex reported a net loss of $13.5 million, or $0.43 per share, for the fourth quarter of 2009 compared to a net loss of $7.5 million, or $0.47 per share, for the fourth quarter of 2008.
› Verified 9 days ago